Qoute: "Whatever's Going To Happen, IsJust About To Happen
With OCAT, that is. "
Yeah, kinda like the Dec "uplist-but-we-really-didn't-uplist" and then into January and nothing; no uplist and no secondary offering and now it's February.
Yep, those old "predictions" have all been pretty much spot on so far? What were the price "predictions" just for the ole "big article" being published (the NON NEJM Lancet article, you know, another "prediction" that sorta missed the mark a tad)? Like $40 to $240 a share- just from that, the imaginary "biggest supposed article in like 100 yrs of supposed medical history", just that alone?
It's parked solid right now barely cracking $6 bucks a share (6 CENTS pre R/S) - pretty much where GARY had it like 5 yrs ago. You know, 2014 being the biggest imaginary year in the entire company history and the supposed like past 100 yrs of medical history and all. All those tall tales. Totally, yep.
And that "uplist" was a slam dunk done deal in 2014, 100% for certain.
Oh yeah. Just "about to happen". Yeah. Sure thing. Right on. Totally.